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JOSEPH S. HANDLER
National Heart, Lung, and Blood Institute, Laboratory of Kidney and Electrolyte Metabolism, Bethesda, Maryland
Prostaglandins (PG's) have effects at several sites
involved in the regulation of water balance. Many
of these are discussed elsewhere in this symposium.
This review will consider vasopressin-PG interac-
tions that are involved in the regulation of water
permeability of epithelia, particularly the renal col-
lecting duct and toad urinary bladder. It is well
established that the increase in permeability to
water that vasopressin elicits in epithelia involves
stimulation of the formation of cyclic AMP [1] and
that PGE inhibits the water permeability response
by inhibiting the stimulation of cyclic AMP forma-
tion [2, 3]. After summarizing the current under-
standing of the cellular action of vasopressin and
the development of ideas and information regarding
the role of PG's in regulating the response to
vasopressin, the mechanisms of the effects of PG's
will be considered, as well as the effect of vasopres-
sin on the metabolism of PG's and related com-
pounds. Finally, the foregoing will be considered in
terms of normal and abnormal regulation of water
permeability.
Effect of vasopression on permeability and
transport
Vasopressin affects water permeability by bind-
ing to specific receptors in the basal-lateral plasma
membrane of the epithelial cells. The binding is
normally coupled to and activates the catalytic unit
of adenylate cyclase in the plasma membrane, re-
sulting in increased formation and accumulation of
cyclic AMP within the epithelial cell. The elevated
level of cyclic AMP induces changes in the apical
plasma membrane that are manifested as increased
permeability to water and to small slightly lipophilic
solutes and increased transport of sodium from
urine to blood. In toad urinary bladder and skin and
perhaps in medullary collecting duct, there is also
increased permeability to urea and related amides.
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Based on studies with toad urinary bladder, it
appears that each of the permeability changes and
the stimulation of sodium transport may be mediat-
ed by a separate vasopressin-sensitive adenylate
cyclase and related pool of cyclic AMP [4]. The
changes in the apical plasma membrane have been
characterized on the basis of indirect evidence.
Each of the changes in permeability and the in-
crease in sodium transport appears to be a manifes-
tation of a separate and perhaps independent alter-
ation in the apical membrane. There is no direct
evidence as to how cyclic AMP elicits these effects.
That aspect of the physiology of the response to
vasopressin, reviewed in more detail elsewhere [5—
7], is not of immediate concern to this discussion
because PG's affect cyclic AMP formation. There is
no evidence that PGE or other arachidonic acid
derivatives act at a more distal step as well.
Inhibition by PGE
It is clear that PGE inhibits the vasopressin-
stimulated adenylate cyclase that mediates the wa-
ter permeability response. The initial evidence was
the inhibition by PGE of the water permeability
response to vasopressin without inhibition of the
water permeability response to exogenous cyclic
AMP in toad urinary bladder [2] and isolated per-
fused cortical collecting duct of the rabbit [3]. The
observations in toad urinary bladder have been
confirmed [8—10], and additional support is provid-
ed by the demonstration that the accumulation of
cyclic AMP in the epithelial cells of the bladder [11]
and in slices of renal medulla [12] exposed to
vasopressin is reduced by low concentrations of
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PGE. The urea permeability response to vasopres-
sin is inhibited by PGE in toad urinary bladder, but
sensitivity to inhibition is less than that of the water
permeability response [101. Modest inhibition by
PGE of the short-circuit current response to vaso-
pressin in toad urinary bladder has been reported by
one laboratory [13] but not confirmed by another [8,
14]. In isolated perfused rabbit cortical collecting
duct, PGE inhibits sodium transport [15, 16]. When
this segment is exposed to physiologic levels of
vasopressin, sodium transport increases transiently
and then falls to rates below control. The reduction
in sodium transport to below the control rate is
prevented by meclofenamate. In the presence of
meclofenamate, it is elicited by PGE [17].
Effect of PGE on adenylate cpclase
Two factors complicated the interpretation of the
early experiments. The first is that in toad urinary
bladder there is "receptor reserve" for cyclic AMP
accumulation relative to the water permeability
response [18]. High concentrations of vasopressin
elicit cyclic AMP production that exceeds the level
required to elicit the maximal water permeability
response. When adenylate cyclase activity is inhib-
ited by PGE, cyclic AMP production in response to
high concentrations of vasopressin is reduced but is
still sufficient to elicit the full water permeability
response, yielding kinetics that superficially appear
to be the result of competitive inhibition by PGE.
The second complication is that in toad urinary
bladder, as in many other tissues, high concentra-
tions of PGE stimulate adenylate cyclase. In the
initial report of the inhibitory effect of PGE in toad
bladder, it was noted that in one series of experi-
ments with a high concentration of PGE (1 M) the
water permeability response to theophylline (an
inhibitor of the degradation of cyclic AMP) was
enhanced [2]. Subsequently, the enhancement of
water flow by high concentrations of PGE in the
presence of theophylline was clearly demonstrated
[14] and related to elevated levels of cell cyclic
AMP [11, 14]. In the isolated perfused cortical
collecting duct, high concentrations (100 pM) of
PGE alone increase water permeability, as do low
concentrations (1 pM) in the presence of theophyl-
line [3]. In addition, in toad urinary bladder [8], but
not in collecting duct [15, 16], in high concentra-
tions, PGE alone has a small stimulatory effect on
sodium transport, undoubtedly the result of in-
creased cyclic AMP production.
The molecular basis of the inhibitory effect of
PGE on vasopressin-stimulated adenylate cyciase is
not known. All of the foregoing concepts regarding
the action of PG's are based on studies with intact
cells. Although small changes have been noted [12,
19, 20], the inhibitory effect of PGE on hormone-
stimulated adenylate cyclase activity has not been
demonstrated convincingly in assays of the enzyme
in broken cell preparations, or in "permeabilized"
medullary collecting ducts dissected from rat kid-
ney [21]. This failure applies as well to PGE inhibi-
tion of hormone-stimulated adenylate cyclase in
other tissues such as fat cells. Apparently, an
essential factor is missing, or some factor in the
standard adenylate cyclase assay interferes with the
demonstration of the inhibitory effect. The situation
may be viewed in terms of a model proposed
recently [22]. In this model, there are three compo-
nents of adenylate cyclase involved in hormonal
stimulation of cyclic AMP production. The compo-
nents are: (1) receptors for the hormone, (2) the
catalytic subunit, and (3) a guanine-nucleotide-bind-
ing subunit that couples hormone receptors to the
catalytic subunit—in cells subject to inhibition of
adenylate cyclase by specific factors such as PG's,
there are two additional components in the plasma
membrane, (4) receptors for the inhibitor (PG's. and
in fat cells adenosine and nicotinic acid as well
[23]), and (5) a guanine-nucleotide-binding subunit
that couples the receptors for inhibitor with adeny-
late cyclase. One would anticipate that all five
components are present in toad urinary bladder and
in collecting duct. In addition, there are probably
receptors for PG's (or a related material) that are
coupled to adenylate cyclase in a mode that stimu-
lates the enzyme. This would explain the stimula-
tory effect of high concentrations of PGE on cyclic
AMP accumulation and on water permeability and
sodium transport.
Production of prostaglandins by vasopressin-sensitii'e
tiss "Cs
Twelve years ago, Grantham and Orloff [3] sug-
gested that PG's, formed within vasopressin-sensi-
tive cells, would serve to dampen the effects of
vasopressin, thereby modulating the water perme-
ability response. Subsequent work in a number of
laboratories has established that PGE is made by
vasopressin-sensitive tissues and ordinarily exerts
an inhibitory effect on the response to vasopressin.
Initially, it was shown that in the toad urinary
bladder, inhibitors of the synthesis of PG's [13, 24,
25] and an antagonist of the action of PG's [13, 26]
enhanced the water permeability response to vaso-
pressin. A similar pattern has been found in the
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mammalian kidney. Inhibitors of PGE synthesis
enhance the renal medullary accumulation of cyclic
AMP [12, 27] and the antidiuretic response of
kidney to vasopressin [27—29]. There is evidence
that the epithelial cells synthesize PGE. Arachi-
donic acid cyclooxygenase, an enzyme involved in
PGE biosynthesis, has been demonstrated in col-
lecting duct cells by immunofluorescence [30] and
epithelial cells scraped from toad urinary bladder
produce PGE (Halushka P, personal communica-
tion).
An important issue under current study is wheth-
er vasopressin affects PGE biosynthesis or the
biosynthesis of other arachidonic acid derivatives,
which in turn might affect the response to vasopres-
sin. Because PGE and other arachidonic acid deriv-
atives do not accumulate in cells but are released
into extracellular fluids, the rate of PGE biosynthe-
sis in vitro is usually estimated by measuring the
rate of appearance of POE in Ringer's solution.
Two laboratories have observed that vasopressin
stimulates the release of POE by the toad urinary
bladder [31, 32]. The release of POE is elicited by
the same low concentrations of vasopressin that
elicit the water permeability response [311, and it
occurs as rapidly [31, 33]. In the foregoing experi-
ments, POE was quantified by radioimmunoas say.
About 95% of the POE appeared in the serosal
solution, 5% in the mucosal solution [311. To deter-
mine the step at which vasopressin stimulates PGE
biosynthesis, bladders were incubated with 3H-
arachidonic acid to label cell stores of the precursor
of PGE. After a control period and after the bladder
was incubated with vasopressin, fatty acids re-
leased into the serosal solution were collected and
separated by thin-layer chromatography, and their
radioactivity was quantified. Radioactivity was in-
creased in regions corresponding to arachidonic
acid and to PGE, indicating that the hormone acted
by stimulating the release of arachidonic acid. This
has been found to be the rate-limiting step in PGE
biosynthesis in renal medullary interstitial cells [34]
and other tissues [351.
The stimulation of PGE biosynthesis in the toad
bladder by vasopressin has not been confirmed in
studies from two other laboratories [36] (Bisordi,
Schlondorff, and Hays, personal communication).
Although there is a difference in analytical tech-
nique, this does not appear to explain the difference
in results. Increased production was observed in
laboratories using the same assay, one that relies on
an antibody to PGB. POB and other prostanoids are
removed by chromatography, and then POE is
converted to PGB and assayed by radioimmunoas-
say. Negative results were obtained in laboratories
using an antibody to POE. Both methods are appar-
ently quite specific for POE in terms of recovery of
PGE added to a sample and the lack of interference
by other known compounds. I can only speculate
on the cause of the different results. It is possible
that an unknown prostanoid is synthesized in re-
sponse to vasopressin and crossreacts with the
antibody to PGB but not with the antibody to PGE.
Seasonal differences in the effect of vasopressin on
PGE production have been noted [321 and might
have contributed to the differences between the two
groups. Unrecognized manipulation of the toad or
the bladder may have obscured or emphasized the
effect of vasopressin. At this time, there is no
reason to favor any of the foregoing as the explana-
tion for the different results.
The evidence regarding vasopressin stimulation
of PGE biosynthesis in mammalian kidney is also
conflicting in that there are species differences. In
addition, the evidence is difficult to evaluate, for
only urinary PG's have been assayed. Urinary PG's
include a portion of circulating PG's that were
filtered or secreted into tubule fluid as well as PG's
that were synthesized within the kidney [37]. The
secretory system for PG's in proximal straight
tubule is inhibited by probenecid and by nonsteroi-
dal antiinflammatory organic acids (indomethacin,
naproxen, ibuprofen) that also inhibit PGE biosyn-
thesis [38—40]. Renal medullary interstitial cells
synthesize PGE. There is no question that the rate
of POE biosynthesis by these cells in culture is
stimulated by vasopressin, as well as by bradykinin
and by angiotensin II [41]. All of these agents act by
stimulating the release of arachidonic acid, the
precursor of POE, from storage sites such as phos-
pholipids [34]. Stimulation of these cells by vaso-
pressin appears to involve receptors that recognize
analogs of the hormone with pressor rather than
antidiuretic activity (Beck, Hassid, and Dunn, per-
sonal communication). 1-Desamino-8-D-arginine
vasopressin (dDAVP), a synthetic analog with anti-
diuretic activity but no pressor activity, has no
effect on POE biosynthesis by the cells in culture.
Biosynthesis is stimulated by analogs with pressor
activity, and this stimulation can be blocked
by d(CH2)5VD-AVP [1 -3-mercapto-3 ,3-cyclopen-
tamethylene propionic acid, 4-valine,8-D-arginine]
vasopressin, a synthetic nonpressor, nonantidiuret-
ic antagonist of vasopressin's pressor activity. Al-
though these cells are located in the interstitium of
the medulla, it is not clear that PG's released at this
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site would enter the urine or reach vasopressin-
sensitive epithelial cells in the cortex of the kidney.
There is evidence that collecting duct cells can
synthesize PG's [21, 301. If PGE synthesized by the
collecting duct distributes as it does in toad urinary
bladder [311, less than 10% of the PGE synthesized
in these vasopressin-sensitive cells would appear in
the urine. Quantitative evaluation of renal metabo-
lism of PGE has been discussed in detail in a recent
review [37]. One must conclude that measurement
of urinary PG's will yield information of limited
value until more is known about the source of
urinary PGE.
Urinary excretion of PG's has been found to be
increased by vasopressin in some but not all spe-
cies. In rats with hereditary pituitary diabetes insip-
idus, urinary excretion of PGE is low and is in-
creased, as it is in normal rats, by injection of
vasopressin [42, 43] or by oral administration of
dDAVP [43]. Vasopressin increases urinary PGE
excretion in rabbits [44], but not in dog [451 or in
man [461. In dog [45] and in man [46], PGE excre-
tion rate appears to vary directly with urine flow
rate.
I am aware of only one study that indicates an
effect of vasopressin on PG biosynthesis by the
collecting duct. The evidence is indirect and was
obtained in experiments with the isolated rabbit
cortical collecting duct perfused in vitro with an
isotonic salt solution. PGE alone has been shown to
inhibit lumen-to-bath sodium transport in this seg-
ment [15, 161. Vasopressin elicits an increase in the
rate of sodium transport [47]. The increase is usual-
ly transient; sodium transport falls to control levels
in 30 mm [17, 471. The fall in sodium transport rate
is blocked by meclofenamate, an inhibitor of cy-
clooxygenase activity and thus of PG biosynthesis.
After treatment with meclofenamate and vasopres-
sin, if PGE is added, the rate of sodium transport
falls [17]. The simplest explanation of these obser-
vations is that vasopressin stimulates adenylate
cyclase activity and thereby stimulates sodium
transport. Vasopressin also stimulates the produc-
tion of PGE or a similar prostanoid whose biosyn-
thesis depends on cyclooxygenase activity. PGE or
the related prostanoid inhibits vasopressin-stimulat-
ed adenylate cyclase and sodium transport in this
segment. Transepithelial electrical potential differ-
ence and lumen-to-bath transport of chloride, calci-
um, and phosphate ions respond as sodium trans-
port responds to vasopressin, meclofenamate, and
PGE [48]. It will be important to confirm these
interesting results that expand the list of transport
processes known to be affected by vasopressin and
by PGE. It may be possible to study the effect of
vasopressin on the biosynthesis of PGE in isolated
collecting ducts using principles similar to those
used to study vasopressin-sensitive adenylate cy-
clase in dissected nephron segments [49]. In a
recent study it was shown that isolated medullary
collecting ducts dissected from rat kidney convert
3H-arachidonic acid to material that behaves like
PGE2 and PGF2c, chromatographically [21]. It
should be possible to label cell stores of arachidonic
acid by incubating dissected nephron segments with
3H-arachidonic acid. Metabolites released in re-
sponse to vasopressin or to a nonpressor analog
with antidiuretic activity such as dDAVP, can be
separated chromatographically and the derivatives
identified to a reasonable degree based on the
chromatographic behavior of standards. Physical
manipulation is known to stimulate PG biosynthesis
in tissues. The dissection and other manipulations
of the tubule in vitro may have such an effect, which
could obscure changes in PG biosynthesis elicited
by vasopressin later in the experiment. For exam-
ple, in the studies in which meclofenamate affected
the electrolyte transport response to vasopressin,
collection periods were begun 300 mm after dissec-
tion and canulation of the tubule [17, 48].
Manipulation of the rate of prostaglandin biosynthesis
Regardless of whether vasopressin stimulates
PGE biosynthesis, it is evident that in the presence
of vasopressin, toad urinary bladder and mammali-
an kidney synthesize PG's at rates sufficient to
inhibit the adenylate cyclase response to the hor-
mone [13, 24, 25, 27]. Therefore, changes in the rate
of PG biosynthesis will be associated with an oppo-
site change in the response to vasopressin. Agents
such as the nonsteroidal antiinflammatory agents
that inhibit PG synthetase enhance the water per-
meability response to vasopressin. Sulfonylureas,
such as chlorpropamide acting like the nonsteroidal
antiinflammatory agents, have a similar effect in
toad urinary bladder [501. Sulfonylureas increase
urinary osmolality in some patients with pituitary
diabetes insipidus [51] and in diabetes insipidus rats
given dDAVP [52]. It has not been established
whether these agents act on the kidney as they do in
toad urinary bladder by inhibiting PG biosynthesis.
Adrenal steroid hormones enhance the water
permeability, sodium transport, and urea perme-
ability response of the toad urinary bladder to
vasopressin [53]. The enhancement is in part the
result of reduced cyclic nucleotide phosphodiester-
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ase activity in bladder epithelial cells incubated
with adrenal steroids [54], and in part the result of
reduced PG biosynthesis [55]. Toad urinary bladder
can be depleted of the effect of adrenal steroid
hormones by several hours of incubation in vitro
without steroids. In the absence or presence of
vasopressin, depleted bladders synthesize more PG
than do bladders incubated with adrenal steroid
hormones. Examination of metabolites released
from bladders labeled with 3H-arachidonic acid
revealed that incubation with adrenal steroid hor-
mones results in inhibition of acylhydrolase activity
that catalyzes the release of arachidonic acid from
tissue stores [55]. Adrenal steroid hormones have
this effect in other tissues that synthesize PG's.
This is regarded as a glucocorticoid effect [56]. It is
probably a glucocorticoid effect in toad urinary
bladder but glucocorticoid-mineralocorticoid differ-
ences are not well defined in amphibia [57]. Adrenal
steroid hormones have a similar effect in mammali-
an renal medullary interstitial cells in culture [56]
and perhaps in the collecting duct as well. There is a
renal concentrating defect in animals with adrenal
insufficiency [58—60]. In a recent study [60], the
water permeability response to 200 pU/ml of argi-
nine vasopressin was markedly depressed in isolat-
ed perfused cortical collecting ducts taken from
adrenalectomized rabbits. The depressed respon-
siveness returned to normal 2 hours after the addi-
tion of 50 M aldosterone or 50 M dexamethasone
in vitro. In additional experiments, the water per-
meability response to 0.1 m 8-Br-cyclic AMP was
normal in collecting ducts from adrenalectomized
rabbits as was the response to a lower concentra-
tion (2 pUIml) of vasopressin in the presence of 0.1
mM 1-methyl-3-isobutylxanthine, a cyclic AMP
phosphodiesterase inhibitor. Because all of the nor-
mal responses, including those of the tubules from
adrenalectomized rabbits, were maximal permeabil-
ity responses, some of the additional experiments
may not have been sensitive enough to detect
reduced responsiveness. Cyclooxygenase inhibitors
have not been used to examine the role of endoge-
nous PG's in the water permeability response of the
isolated cortical collecting duct of normal rabbits to
vasopressin. Whether PG's play a role in the de-
pressed water permeability response of the cortical
collecting duct of adrenalectomized rabbits also
remains to be determined. Because there is a renal
concentrating defect [57—59], it might be fruitful to
study renal PG metabolism and the response to
vasopressin in adrenalectomized animals. It is inter-
esting to note the very low concentration (5 pM) of
aldosterone or dexamethasone that reversed the
defect in vitro, indicating marked sensitivity to a
mineralocorticoid or glucocorticoid hormone.
Prostaglandin production may also be affected by
pH. The water permeability response of the toad
urinary bladder to vasopressin is inhibited as sero-
sal pH is lowered, whereas the response to cyclic
AMP is unaffected or enhanced [61, 62]. Apparently
PGE production increases as pH of the serosal
solution is lowered from a pH of 8.0 to 7.4, a pattern
compatible with the suggestion that serosal acidifi-
cation inhibits the water flow response to vasopres-
sin in part by stimulating the biosynthesis of PGE
[36].
Effect of other arachidonic acid derivatives
In view of the large and increasing number of
arachidonic acid derivatives that have been identi-
fied and found to be active in a variety of tissues, it
is possible that derivatives other than the PG's
affect the response to vasopressin. Recent work has
provided evidence that thromboxane A2 may affect
water permeability of the toad urinary bladder.
Initially, thromboxane B2, the metabolite of throm-
boxane A2, was identified by gas chromatography
mass spectroscopy in Ringer's solution in which
bladders had been incubated [32]. In that study,
thromboxane B2 and PGE were quantified by radio-
immunoassay. Both derivatives were found in the
Ringer's solution bathing the serosal surface of the
bladder. The biosynthesis of both was increased by
vasopressin during the period of the water perme-
ability response. In additional studies, indirect evi-
dence was obtained that thromboxanes, synthe-
sized in response to vasopressin, have a stimulatory
effect on the water permeability response. An inhib-
itor of thromboxane biosynthesis, 7-( 1 -imidazolyl)-
heptanoic acid (7-IHA) inhibited thromboxane B2
production and the water permeability response to
vasopressin without affecting PGE production.
Similarly, a thromboxane antagonist, 1 3-azapros-
tanoic acid (13-APA), inhibited the water perme-
ability response to vasopressin. The inhibitory ef-
fects of 7-IHA and of 13-APA were dependent on
endogenous thromboxane biosynthesis in that they
had no effect if thromboxane and PGE biosynthesis
were inhibited by meclofenamate or indomethacin
[331. Neither 7-IHA or 1 3-APA affected the water
permeability response to cyclic AMP, perhaps be-
cause cyclic AMP does not stimulate thromboxane
biosynthesis [33], or because thromboxanes, like
PGE, act at a step that affects the production of
cyclic AMP. When the effects of endogenous
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thromboxanes were inhibited, the maximal inhibi-
tion of water flow was about 30%, indicating that
the portion of the water permeability response to
vasopressin that is enhanced by vasopressin-stimu-
lated thromboxane biosynthesis is not large.
In view of the indirect nature of the foregoing
evidence, attempts have been made to stimulate
water flow directly with thromboxanes or throm-
boxane-like agents [63]. In these experiments, the
effects of endogenous arachidonic acid derivatives
were eliminated by incubating bladders in meclo-
fenamate or indomethacin. Because the active de-
rivative thromboxane A2 is relatively unstable,
thromboxane B2 in high concentrations (25 pM) and
two stable PG endoperoxide analogs that have been
shown to have thromboxane-A2-like effects in other
tissues were tested. Each of the agents alone in-
creased the water permeability of the bladder. The
effect of the thromboxane-like agents was blocked
by 13-APA, the thromboxane antagonist that inhib-
ited the water permeability response to vasopres-
sin. The foregoing evidence supports the suggestion
that vasopressin stimulates thromboxane A2 bio-
synthesis by the toad urinary bladder and that
thromboxane A2 elicits part of the increase in
permeability to water [63]. In a preliminary report
[641, however, the endoperoxide analogs inhibited
the water permeability response of the toad urinary
bladder to vasopressin. The discrepancy between
the reports has been attributed to another effect of
the endoperoxide analogs. They cause contraction
of the smooth muscle of the bladder. In view of this
additional effect, which could easily distort esti-
mates of water permeability, it would be better to
test these agents on the water permeability of frog
or toad skin or the isolated perfused cortical collect-
ing duct. If the stimulatory effect of thromboxanes
on water permeability is confirmed, it will be impor-
tant to ascertain whether thromboxane A2 acts by
stimulating adenylate cyclase, as would seem like-
ly. Although thromboxanes and PGE usually have
opposing effects, it may be that the stimulation of
water permeability by high concentrations of PGE
is the result of interaction with receptors for throm-
boxane A2.
Homogenates of renal cortex and of renal medul-
la can synthesize prostacyclin (PGI2), thromboxane
A2, and PGF2, as well as PGE2 [651. The role of the
other derivatives in the renal response to vasopres-
sin is unknown. The effect of some of the other
arachidonic acid derivatives has been examined in
toad urinary bladder. PGF, PGA, and PGB were
less potent than was PGE as inhibitors of the water
permeability response to vasopressin [9].
Biological importance of the inhibition of adenylate
cyclase by prostaglandin E
There is now abundant evidence to support the
suggestion [3] that PGE synthesized in vasopressin-
sensitive cells dampens the water permeability re-
sponse to vasopressin. PGE and other arachidonic
acid derivatives may have a more complex role as
well. It is apparent that changes in the response to
vasopressin can be produced by changes in the rate
of PGE biosynthesis. Therefore, regulation of the
pathway for PG biosynthesis may serve as a path-
way by which the response to vasopressin is regu-
lated by other factors, for example, the marked
effect of adrenal steroid hormones [53, 60]. Further-
more, in view of the evidence that the water perme-
ability, urea permeability, and sodium transport
responses to vasopressin have different sensitivity
to the inhibitory effect of PGE [10, 13], changes in
PGE biosynthesis will affect these responses to a
different degree. Thus, regulation of PGE biosyn-
thesis may also serve to alter the balance or in a
sense discriminate among the responses to vaso-
pressin.
Abnormalities of metabolism of arachidonic acid
or its derivatives may affect water permeability
profoundly. High concentrations of thromboxane
A2 or very high concentrations of PGE would have
a vasopressin-like effect on water permeability;
lower but elevated levels of PGE would inhibit the
response to vasopressin; abnormally low levels of
PGE would result in loss of the dampening effect.
Many issues remain unresolved. Among these are
the effect of vasopressin on the metabolism of
arachidonic acid and its derivatives in epithelial
cells and the specific effect of other derivatives such
as thromboxane A2. Perhaps the most important
advance will be the development of a better prepa-
ration for studying interactions between vasopres-
sin, arachidonic acid and PG in renal epithelia.
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